That's crucial, since the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work. Simply put, we have to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error procedure (future report review). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a development practically nobody saw. But it's going to have extensive ramifications for treating disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be plenty of financial investment opportunities in this space, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (last week). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it drew back possibly significantly prior to going higher - jeff brown predictions for 2021. I've been covering bitcoin for a very long time now. Among the first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mostly informing readers. However that's not the huge question any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. self-driving cars. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are so many excellent private companies on the verge of hitting the public markets And I have actually been dealing with a new method for you to invest even prior to these business go public.
This chance has actually been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the information. Go right here to reserve your spot totally free.
Emma Walsh here, managing editor of the Diary. Routine Diary readers know that tech isn't our normal beat (jeff brown stock picks 2021). And when it pertains to tech investing, we leave it to the professionals. Fortunately, we have a number of such professionals in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing specialists we understand (korean actress). In reality, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the big picture and forecast what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and far more. These patterns are experiencing exponential development and creating amazing chances for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown investor prediction. But in spite of what lots of readers may think, this is a trend that's simply beginning. Although the COVID-19 pandemic interfered with supply chains in 2015, an outstanding 250 million 5G-enabled devices were still offered.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown). Losing two months of manufacturing and sales actually impacts how many 5G gadgets are offered in the calendar year. When you consider all of that, offering 250 million systems is impressive. More significantly, the hold-ups triggered by the pandemic created a heap of suppressed demand. And that demand is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G gadgets will be delivered in 2021 - genetic sequencer stock jeff brown. And that's not my only 5G prediction When I have actually discussed 5G in the past, I have actually described its three various stages.
In Phase Two, 5G devices go on sale. 5G phones and other items begin to reach customers. And in Phase Three, 5G services start to be used (jeff brown 2021 stock predictions). That's when we begin to see applications working on 5G networks. Think about things like huge multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Phase Three by this summer. This starts something of a virtuous cycle: A lot of people don't really appreciate the technology. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In fact, 5G is going to open a suite of incredible applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these technologies need 5G. The financial investment chances moving forward will be massive. Stepping away from 5G, the next important innovation I anticipate in 2021 is CRISPR genetic modifying. CRISPR means "clustered frequently interspaced brief palindromic repeat." It's a mouthful. However it's one of the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not function properly. CRISPR utilizes a comparable concept however with our hereditary code. "Typos" in our genome can cause disease. CRISPR can correct these "typos." For several years, CRISPR was mainly a niche innovation that wasn't well comprehended. And during that time, there were really just 3 business operating in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're treating illness and seeing that this technology simply works. And as a result, a "second crop" of early-stage CRISPR companies is going public and providing incredible returns. This whole market is successfully a greenfield opportunity.
There's room for many business to exist in this space. jeff brown market predictions. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that two or 3 more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software can properly anticipate the folding of a protein based solely on its amino acid series with 92. 4% precision. That is necessary because the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and be efficient.
Historically, this has been a trial-and-error procedure. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but several drug treatments produced utilizing this technology. This was one of those developments that practically no one noticed. However it's going to have profound ramifications for curing disease. And, of course, there will be plenty of investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe substantially prior to going higher. I've been covering bitcoin for a very long time now. Among the first research study reports I ever released was on bitcoin - jeff brown. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. But at the time of that initial suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But no one is asking that question any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. angel investor. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the details is up to date since February 2021, but we could not individually confirm this claim. Given Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an exact figure at this minute. Brown is best known for his sage-like ability to select winning technology stocks. He invested more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an excellent point of view on the market. He's constantly on the hunt for brand-new chances, and he shares a lot of his finest choices in the Near Future Report.
That's high praise, but it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he successfully anticipated some of the most significant financial events of the past twenty years. Although he does not appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it best each time, but Jeff Brown's accurate forecasts have made him legions of dedicated followers. That says a lot about his capability. The Near Future Report is published by Brownstone Research, a popular monetary research publisher. Brownstone Research offers a number of research services with a large variety of expertises - jeff brown predictions for 2021.
The business is also connected with Bonner & Partners, another well-respected research study publisher - the legacy report predictions. On its website, Brownstone says its mission is to provide retail investors with professional-grade research study: "For too long, the best investment research study has not been offered to individual financiers. It has actually been normally scheduled for investment banks, hedge funds, private equity, and high-net-worth customers. white house. The mission of Brownstone Research is to make that sort of exclusive research available to any financiers wanting to get an edge in the markets. The goal is basic to deliver distinct and rewarding investment research study found no place else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research, and he also works as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After decades of steady success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout most of America. If you know even a little bit about the market, you know that he has a reputation as a King Midas of sorts. jeff brown biotech pick. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown thinks S.A.V. genetic sequencer stock jeff brown. might be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be weding 2 advanced innovations: artificial intelligence and electric automobiles. Musk hopes the mix will help him develop the first fully-autonomous, self-driving cars ever. It's absolutely nothing except the automobile market's Holy Grail. As you understand, electrical automobiles and self-driving cars and truck stocks have been substantial this year, however the Wall Street device has approved hype without much tangible result. Regardless of a drastic increase in competition over the previous few years, Brown still believes Musk has the very best chance of putting it all together.
tech could be the magic string that ties it all together. S.A.V. means Shared Autonomous Automobile, and it might be the future of transportation. Basically, this innovation would allow you to rent your cars and truck as a self-governing, self-driving taxi when you're not using it. You just leave the cars and truck and press a button on an app that informs the cars and truck to "join the fleet." Next thing you know, you're unwinding on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a significant portion of the revenues. It sounds crazy, however it might be closed than you believe.